The Forever Healthy Foundation has announced the first set of speakers for its Rejuvenation Startup Summit on 10-11 May 2024.
The networking event brings together startups and members of the longevity venture capital and investor ecosystem who share the common aim to create therapies that extend the healthy human lifespan.
Rejuvenation and longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse the diseases of ageing by addressing their common root cause, the ageing process itself.
In addition to a range of presentations from CEOs of startups in the fields of rejuvenation and longevity, the summit features an all-day startup forum for networking, panel discussions and keynote presentations.
The summit will take place in Berlin and starts at midday on Friday 10 May and finishes on Saturday 11 with an evening party for all attendees.
Speakers at the event will include Michael Greve, founder of the Forever Healthy Foundation; Nina Ruge, science journalist and best-selling author; Hans S. Keirstead, chairman of the Board of Immunis Inc, Dobri Kiprov, co-founder and CSO of Lyfspn, Jens Eckstein, investment partner at Hevolution and, Sergey Jakimov, managing partner at LongeVC.
Other speakers will include spokespeople from the likes of Intervene Immune, Reservoir Neuroscience, Rubedo Life Sciences, Deciduous Therapeutics, Elastrin Therapeutics, LIfT BioSciences, Rejuvenate Biomed, NUS Singapore and Healthy Longevity Clinic
Speakers at the Rejuvenation Startup Summit will include:
- Michael Greve, Founder of the Forever Healthy Foundation
- Nina Ruge, science journalist and best-selling author
- Hans S. Keirstead, Chairman of the Board of Immunis Inc. – developing immune secretome products to change the course of immune-related diseases and ageing
- Dobri Kiprov, Co-founder and CSO of Lyfspn – conducting a pilot study on Plasmapheresis
- Greg Fahy, Co-founder and CSO, and Bobby Brooke, CEO and CTO of Intervene Immune – the thymus regeneration pioneer
- Aaron Friedman, Co-founder and CEO, and Vlad Senatorov, Co-founder and CSO of Reservoir Neuroscience P rejuvenate the blood-brain barrier and restore vascular health
- Marco Quarta, Co-founder and CEO Rubedo Life Sciences – keeps you biologically young by targeting the pathologic cells that drive aging
- Robin Mansukhani, CEO of Deciduous Therapeutics – developing multiple activation approaches to clearing senescent cells via novel immunotherapies
- Matthias Breugelmans, CEO, and Naren Vyavahare, CSO of Elastrin Therapeutics – leveraging a platform to develop therapeutics that render calcified tissue and organs supple again
- Alex Blyth, CEO of LIfT BioSciences – developing the world’s first ‘off-the-shelf’ cell therapy to destroy all solid tumors irrespective of their origin
- Ann Belien, CEO of Rejuvenate Biomed – researches the biology of aging and evaluates the therapeutic potential of synergistic combination drugs
- Mike Kope, and Matthew O’Connor, Co-CEOs of Cyclarity – prevents age-related conditions such as atherosclerosis, heart attack, and stroke by addressing the root cause
- Aaron Cravens, CEO of REVEL – opens up an entirely new field in the treatment of age-related molecular damage by breaking cross-linked collagen fibers
- Matthew Rosen, Executive Vice Chairman of CoRegen – leveraging its gene regulatory platform for the treatment of cancers and other chronic illnesses
- Janine Sengstack, Co-founder and CEO, and Rob Carhill, Co-Founder and President of Junevity – rewinding diseases of age with novel transcription factor targeting medicines
- Reason, CEO and Mourad Topors, CSO of Repair Biotechnologies – developing therapies based on the Cholesterol Degrading Platform
- Alexander Leutner, Managing Director of cellbricks – replicating human tissue at scale
- Alexander Schueller, CEO, and Stephen Helliwell, CSO of cellvie – pioneering Therapeutic Mitochondria Transplantation
- Lou Hawthorne, Founder and CEO of NaNotics – developing a new class of medicine
- Phil Newman, Founder and CEO of Longevity.Technology
- Stephanie Dainow, Executive Director of Lifespan.io
- Lorna Harries, CSO of Senisca – developing senotherapeutic interventions to target the diseases and aesthetic signs of ageing
- Jürgen Reeß, CEO of Mogling Bio – developing approaches to rejuvenate old stem cells of the hematopoietic (blood cell formation) system
- Petr Sramek, Co-founder of the Healthy Longevity Clinic and Managing Partner of LongevityTech.fund
- Brian Kennedy, Prof. NUS Singapore
- Eric Verdin, CEO and president of the Buck Institute for Research on Aging
Investors on stage:
- Jens Eckstein, Investment Partner at Hevolution
- Alex Colville, Co-founder, General Partner at Age1
- Jan Adams, Partner at Apollo Health Ventures
- Sergey Jakimov, Managing Partner at LongeVC
- Marc P. Bernegger, Founding Partner at maximon
- Patrick Burgermeister, Partner at Kizoo Technology Capital